OptiBiotix Health (LON:OPTI) Reaches New 12-Month Low – What’s Next?

OptiBiotix Health Plc (LON:OPTI)’s stock price reached a new 52-week low during mid-day trading on Friday. The stock traded as low as GBX 4.50 and last traded at GBX 4.55, with a volume of 168,245 shares. The stock had previously closed at GBX 4.55.

OptiBiotix Health Price Performance

The stock has a market cap of £4.70 million, a P/E ratio of -1.08 and a beta of 1.82. The business’s 50 day simple moving average is GBX 5.78 and its 200 day simple moving average is GBX 5.85.

OptiBiotix Health (LON:OPTI) last issued its earnings results on Thursday, September 17th. The company reported GBX (1.52) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative return on equity of 77.85% and a negative net margin of 332.69%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.